ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,636,381 | -1.2% | 16,658,207 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $60,387,302 | +11.3% | 16,365,122 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $54,255,266 | -7.4% | 16,391,319 | +8.5% | 0.00% | 0.0% |
| Q4 2022 | $58,592,970 | +85.8% | 15,101,281 | +16.4% | 0.00% | +100.0% |
| Q3 2022 | $31,532,000 | +26.5% | 12,975,594 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $24,931,000 | +231.7% | 12,590,726 | +206.5% | 0.00% | – |
| Q1 2022 | $7,517,000 | +30.8% | 4,107,382 | +0.8% | 0.00% | – |
| Q4 2021 | $5,746,000 | +116.3% | 4,075,591 | +73.3% | 0.00% | – |
| Q3 2021 | $2,657,000 | -23.7% | 2,351,367 | +7.9% | 0.00% | – |
| Q2 2021 | $3,484,000 | -65.6% | 2,178,232 | -62.1% | 0.00% | – |
| Q1 2021 | $10,126,000 | -4.3% | 5,753,820 | +6.1% | 0.00% | – |
| Q4 2020 | $10,576,000 | -19.1% | 5,423,699 | -0.9% | 0.00% | – |
| Q3 2020 | $13,077,000 | -22.0% | 5,471,876 | -4.4% | 0.00% | -100.0% |
| Q2 2020 | $16,767,000 | +9.8% | 5,721,937 | +8.0% | 0.00% | 0.0% |
| Q1 2020 | $15,265,000 | -3.9% | 5,300,167 | +33.5% | 0.00% | 0.0% |
| Q4 2019 | $15,884,000 | +13.5% | 3,971,107 | +26.3% | 0.00% | 0.0% |
| Q3 2019 | $13,994,000 | +90.6% | 3,145,072 | +65.7% | 0.00% | – |
| Q2 2019 | $7,343,000 | +98.0% | 1,897,484 | +94.0% | 0.00% | – |
| Q1 2019 | $3,708,000 | +60.9% | 978,224 | +1.4% | 0.00% | – |
| Q4 2018 | $2,305,000 | -61.3% | 964,349 | +0.5% | 0.00% | – |
| Q3 2018 | $5,959,000 | +36.1% | 959,772 | -1.1% | 0.00% | – |
| Q2 2018 | $4,378,000 | +2253.8% | 970,839 | +2295.0% | 0.00% | – |
| Q1 2018 | $186,000 | +129.6% | 40,536 | +59.5% | 0.00% | – |
| Q4 2017 | $81,000 | +62.0% | 25,421 | +59.0% | 0.00% | – |
| Q3 2017 | $50,000 | -19.4% | 15,987 | -5.2% | 0.00% | – |
| Q2 2017 | $62,000 | -33.3% | 16,856 | -11.6% | 0.00% | – |
| Q1 2017 | $93,000 | – | 19,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |